Cornelia L. Dekker, M.D.

Professor (Research) of Pediatrics (Infectious Diseases)

Professional Education

Board Certification: Pediatrics, American Board of Pediatrics (1981)

Medical Education: Michigan State University (1976) MI

Fellowship: Duke University Medical Center (1982) NC

Residency: Duke University Medical Center (1979) NC

Internship: Duke University Medical Center (1977) NC

B.S., Michigan State University, Microbiology & Public Health, Human Clinical Medicine (1973)

M.D., Michigan State University, Medicine (1976)

Honors & Awards

Junior Faculty Award, SmithKlein Beecham (07/05/00-07/04/02)

Excellence in Teaching, Stanford Univ. School of Medicine (06/23/08)

Administrative Appointments

Medical Director, Stanford-LPCH Vaccine Program (1999 - Present)

Member, Department of Pediatrics Research Advisory Committee (2009 - Present)

Member, Department of Pediatrics Administrative Advisory Committee (2008 - 2009)

IRB Reviewer, Stanford Administrative Panel on Human Subjects in Medical Research, Panel 3 (2002 - Present)

Member, Stanford GCRC Advisory Committee (2006 - Present)

Distinct Cross-reactive B-Cell Responses to Live Attenuated and Inactivated Influenza Vaccines.
Sasaki, S., Holmes, T. H., Albrecht, R. A., García-Sastre, A., Dekker, C. L., & Greenberg, H. B. (2014). Distinct Cross-reactive B-Cell Responses to Live Attenuated and Inactivated Influenza Vaccines. journal of infectious diseases, 210(6), 865-874.

Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements.
Jackson, K. Jl., Liu, Y., Roskin, K. M., Glanville, J., Hoh, R. A., & Boyd, S. D. (2014). Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell host & microbe, 16(1), 105-114.

Live Vaccine Use and Safety in DiGeorge Syndrome
Hofstetter, A. M., Jakob, K., Klein, N. P., Dekker, C. L., Edwards, K. M., & LaRussa, P. (2014). Live Vaccine Use and Safety in DiGeorge Syndrome. PEDIATRICS, 133(4), E946-E954.

Effects of Aging, Cytomegalovirus Infection, and EBV Infection on Human B Cell Repertoires
Wang, C., Liu, Y., Xu, L. T., Jackson, K. Jl., Roskin, K. M., & Boyd, S. D. (2014). Effects of Aging, Cytomegalovirus Infection, and EBV Infection on Human B Cell Repertoires. JOURNAL OF IMMUNOLOGY, 192(2), 603-611.

Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination
Furman, D., Hejblum, B. P., Simon, N., Jojic, V., Dekker, C. L., & Davis, M. M. (2014). Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 111(2), 869-874.

Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: Reports to VAERS
Halsey, N. A., Griffioen, M., Dreskin, S. C., Dekker, C. L., Wood, R., & Kelso, J. M. (2013). Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: Reports to VAERS. VACCINE, 31(51), 6107-6112.

Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults.
Creech, C. B., Dekker, C. L., Ho, D., Phillips, S., Mackey, S., & Edwards, K. M. (2013). Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults. Human vaccines & immunotherapeutics, 9(12), 2548-2557.

Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry.
Horowitz, A., Strauss-Albee, D. M., Leipold, M., Kubo, J., Nemat-Gorgani, N., & Blish, C. A. (2013). Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Science translational medicine, 5(208), 208ra145-?.

Genetic measurement of memory B-cell recall using antibody repertoire sequencing
Vollmers, C., Sit, R. V., Weinstein, J. A., Dekker, C. L., & Quake, S. R. (2013). Genetic measurement of memory B-cell recall using antibody repertoire sequencing. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(33), 13463-13468.

Comprehensive assessment of serious adverse events following immunization by health care providers.
Williams, S. E., Edwards, K. M., Baxter, R. P., LaRussa, P. S., Halsey, N. A., & Klein, N. P. (2013). Comprehensive assessment of serious adverse events following immunization by health care providers. journal of pediatrics, 162(6), 1276-?.

Characterization of Influenza Vaccine Immunogenicity Using Influenza Antigen Microarrays
Price, J. V., Jarrell, J. A., Furman, D., Kattah, N. H., Newell, E., & Utz, P. J. (2013). Characterization of Influenza Vaccine Immunogenicity Using Influenza Antigen Microarrays. PLOS ONE, 8(5).

Lineage structure of the human antibody repertoire in response to influenza vaccination.
Jiang, N., He, J., Weinstein, J. A., Penland, L., Sasaki, S., & Quake, S. R. (2013). Lineage structure of the human antibody repertoire in response to influenza vaccination. Science translational medicine, 5(171), 171ra19-?.

Clinical Assessment of Serious Adverse Events in Children Receiving 2009 H1N1 Vaccination
Pahud, B. A., Williams, S. E., Dekker, C. L., Halsey, N., LaRussa, P., & Edwards, K. M. (2013). Clinical Assessment of Serious Adverse Events in Children Receiving 2009 H1N1 Vaccination. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 32(2), 163-168.

Heterovariant Cross-Reactive B-Cell Responses Induced by the 2009 Pandemic Influenza Virus A Subtype H1N1 Vaccine
He, X.-S., Sasaki, S., Baer, J., Khurana, S., Golding, H., & Greenberg, H. B. (2013). Heterovariant Cross-Reactive B-Cell Responses Induced by the 2009 Pandemic Influenza Virus A Subtype H1N1 Vaccine. JOURNAL OF INFECTIOUS DISEASES, 207(2), 288-296.

Characterization of influenza vaccine immunogenicity using influenza antigen microarrays.
Price, J. V., Jarrell, J. A., Furman, D., Kattah, N. H., Newell, E., & Utz, P. J. (2013). Characterization of influenza vaccine immunogenicity using influenza antigen microarrays. PloS one, 8(5).

Apoptosis and other immune biomarkers predict influenza vaccine responsiveness.
Furman, D., Jojic, V., Kidd, B., Shen-Orr, S., Price, J., & Davis, M. M. (2013). Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Molecular systems biology, 9, 659-?.

Biologically plausible and evidence-based risk intervals in immunization safety research
Rowhani-Rahbar, A., Klein, N. P., Dekker, C. L., Edwards, K. M., Marchant, C. D., & Baxter, R. (2012). Biologically plausible and evidence-based risk intervals in immunization safety research. VACCINE, 31(1), 271-277.

Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
Loughlin, A. M., Marchant, C. D., Adams, W., Barnett, E., Baxter, R., & Jakob, K. (2012). Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). VACCINE, 30(50), 7253-7259.

Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons
Jackson, L. A., Chen, W. H., Stapleton, J. T., Dekker, C. L., Wald, A., & Wolff, M. C. (2012). Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons. JOURNAL OF INFECTIOUS DISEASES, 206(6), 811-820.

Algorithm to assess causality after individual adverse events following immunizations
Halsey, N. A., Edwards, K. M., Dekker, C. L., Klein, N. P., Baxter, R., & Vellozzi, C. (2012). Algorithm to assess causality after individual adverse events following immunizations. VACCINE, 30(39), 5791-5798.

Lack of association between childhood immunizations and encephalitis in California, 1998-2008
Pahud, B. A., Rowhani-Rahbar, A., Glaser, C., Gavali, S., Salibay, C. J., & Dekker, C. L. (2012). Lack of association between childhood immunizations and encephalitis in California, 1998-2008. VACCINE, 30(2), 247-253.

Developing the next generation of vaccinologists
Klein, N. P., Gidudu, J., Qiang, Y., Pahud, B., Rowhani-Rahbar, A., & DeStefano, F. (2011). Developing the next generation of vaccinologists. VACCINE, 29(50), 9296-9297.

Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults
Kennedy, J. S., Gurwith, M., Dekker, C. L., Frey, S. E., Edwards, K. M., & Greenberg, R. N. (2011). Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults. JOURNAL OF INFECTIOUS DISEASES, 204(9), 1395-1402.

Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination
Williams, S. E., Pahud, B. A., Vellozzi, C., Donofrio, P. D., Dekker, C. L., & Edwards, K. M. (2011). Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination. VACCINE, 29(46), 8302-8308.

Rotavirus shedding in premature infants following first immunization
Smith, C. K., McNeal, M. M., Meyer, N. R., Haase, S., & Dekker, C. L. (2011). Rotavirus shedding in premature infants following first immunization. VACCINE, 29(45), 8141-8146.

Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009
Williams, S. E., Klein, N. P., Halsey, N., Dekker, C. L., Baxter, R. P., & Edwards, K. M. (2011). Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009. VACCINE, 29(40), 6920-6927.

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone (R)) administered by intradermal and intramuscular route in healthy adults
Frenck, R. W., Belshe, R., Brady, R. C., Winokur, P. L., Campbell, J. D., & Tornieporth, N. (2011). Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone (R)) administered by intradermal and intramuscular route in healthy adults. VACCINE, 29(34), 5666-5674.

Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies
Sasaki, S., Sullivan, M., Narvaez, C. F., Holmes, T. H., Furman, D., & He, X.-S. (2011). Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. JOURNAL OF CLINICAL INVESTIGATION, 121(8), 3109-3119.

Attitudes and Beliefs of Parents Concerned About Vaccines: Impact of Timing of Immunization Information
Vannice, K. S., Salmon, D. A., Shui, I., Omer, S. B., Kissner, J., & Gust, D. A. (2011). Attitudes and Beliefs of Parents Concerned About Vaccines: Impact of Timing of Immunization Information. PEDIATRICS, 127, S120-S126.

Understanding the Role of Human Variation in Vaccine Adverse Events: The Clinical Immunization Safety Assessment Network
Larussa, P. S., Edwards, K. M., Dekker, C. L., Klein, N. P., Halsey, N. A., & Slade, B. A. (2011). Understanding the Role of Human Variation in Vaccine Adverse Events: The Clinical Immunization Safety Assessment Network. PEDIATRICS, 127, S65-S73.

Plasmablast-derived polyclonal antibody response after influenza vaccination
He, X.-S., Sasaki, S., Narvaez, C. F., Zhang, C., Liu, H., & Greenberg, H. B. (2011). Plasmablast-derived polyclonal antibody response after influenza vaccination. JOURNAL OF IMMUNOLOGICAL METHODS, 365(1-2), 67-75.

Varicella Zoster Disease of the Central Nervous System: Epidemiological, Clinical, and Laboratory Features 10 Years after the Introduction of the Varicella Vaccine
Pahud, B. A., Glaser, C. A., Dekker, C. L., Arvin, A. M., & Schmid, D. S. (2011). Varicella Zoster Disease of the Central Nervous System: Epidemiological, Clinical, and Laboratory Features 10 Years after the Introduction of the Varicella Vaccine. JOURNAL OF INFECTIOUS DISEASES, 203(3), 316-323.

Preterm Infants' T Cell Responses to Inactivated Poliovirus Vaccine
Klein, N. P., Gans, H. A., Sung, P., Yasukawa, L. L., Johnson, J., & Dekker, C. L. (2010). Preterm Infants' T Cell Responses to Inactivated Poliovirus Vaccine. JOURNAL OF INFECTIOUS DISEASES, 201(2), 214-222.

Vaccine effectiveness against laboratory-confirmed influenza in infants: A matched case control study.
Cochran, L. W., Black, S., Klein, N. P., Dekker, C. L., Lewis, E., & Reingold, A. L. (2010). Vaccine effectiveness against laboratory-confirmed influenza in infants: A matched case control study. Human vaccines, 6(9).

Differential maternal responses to a newly developed vaccine information pamphlet
Klein, N. P., Kissner, J., Aguirre, A., Sparks, R., Campbell, S., & Gust, D. A. (2009). Differential maternal responses to a newly developed vaccine information pamphlet. VACCINE, 28(2), 323-328.

Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults
Keitel, W. A., Dekker, C. L., Mink, Ca., Campbell, J. D., Edwards, K. M., & Hill, H. (2009). Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults. VACCINE, 27(47), 6642-6648.

One Step Closer to a CMV Vaccine
Dekker, C. L., & Arvin, A. M. (2009). One Step Closer to a CMV Vaccine. NEW ENGLAND JOURNAL OF MEDICINE, 360(12), 1250-1252.

Adolescent Vaccination Recommendations from the National Vaccine Advisory Committee
Freed, G. L. (2009). Adolescent Vaccination Recommendations from the National Vaccine Advisory Committee. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 36(3), 278-279.

Recurrent sterile abscesses following aluminium adjuvant-containing vaccines.
Klein, N. P., Edwards, K. M., Sparks, R. C., & Dekker, C. L. (2009). Recurrent sterile abscesses following aluminium adjuvant-containing vaccines. BMJ case reports, 2009.

An algorithm for treatment of patients with hypersensitivity reactions after vaccines
Wood, R. A., Berger, M., Dreskin, S. C., Setse, R., Engler, R. Jm., & Halsey, N. A. (2008). An algorithm for treatment of patients with hypersensitivity reactions after vaccines. PEDIATRICS, 122(3), E771-E777.

Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses
Sasaki, S., He, X.-S., Holmes, T. H., Dekker, C. L., Kemble, G. W., & Greenberg, H. B. (2008). Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses. PLOS ONE, 3(8).

The promise and challenge of adolescent immunization
Freed, G. L., Almquist, J. R., Birkhead, G. S., Dekker, C., Feinberg, M., & Young, A. E. (2008). The promise and challenge of adolescent immunization. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 35(2), 152-157.

Mandates for adolescent immunizations - Recommendations from the National Vaccine Advisory Committee
Freed, G. L., Almquist, J. R., Birkhead, G. S., Dekker, C., Feinberg, M., & Young, A. E. (2008). Mandates for adolescent immunizations - Recommendations from the National Vaccine Advisory Committee. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 35(2), 145-151.

Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine
Talbot, H. K., Keitel, W., Cate, T. R., Treanor, J., Campbell, J., & Edwards, K. M. (2008). Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. VACCINE, 26(32), 4057-4061.

Baseline Levels of Influenza-Specific CD4 Memory T-Cells Affect T-Cell Responses to Influenza Vaccines
He, X.-S., Holmes, T. H., Sasaki, S., Jaimes, M. C., Kemble, G. W., & Greenberg, H. B. (2008). Baseline Levels of Influenza-Specific CD4 Memory T-Cells Affect T-Cell Responses to Influenza Vaccines. PLOS ONE, 3(7).

Phenotypic changes in influenza-specific CD8(+) T cells after immunization of children and adults with influenza vaccines
He, X.-S., Holmes, T. H., Mahmood, K., Kemble, G. W., Dekker, C. L., & Greenberg, H. B. (2008). Phenotypic changes in influenza-specific CD8(+) T cells after immunization of children and adults with influenza vaccines. JOURNAL OF INFECTIOUS DISEASES, 197(6), 803-811.

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults
Bernstein, D. I., Edwards, K. M., Dekker, C. L., Belshe, R., Talbot, H. Kb., & Hill, H. (2008). Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults. JOURNAL OF INFECTIOUS DISEASES, 197(5), 667-675.

A role for genetics in the immune response to the varicella vaccine
Klein, N. P., Fireman, B., Enright, A., Ray, P., Black, S., & Dekker, C. L. (2007). A role for genetics in the immune response to the varicella vaccine. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 26(4), 300-305.

Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine
Zeman, A. M., Holmes, T. H., Stamatis, S., Tu, W., He, X.-S., & Dekker, C. L. (2007). Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 26(2), 107-115.

Comparison of the influenza virus-specific effector and memory C-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines
Sasaki, S., Jaimes, M. C., Holmes, T. H., Dekker, C. L., Mahmood, K., & Greenberg, H. B. (2007). Comparison of the influenza virus-specific effector and memory C-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. JOURNAL OF VIROLOGY, 81(1), 215-228.

Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines
He, X.-S., Holmes, T. H., Zhang, C., Mahmood, K., Kemble, G. W., & Arvin, A. M. (2006). Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. JOURNAL OF VIROLOGY, 80(23), 11756-11766.

Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults
Klein, N. P., Holmes, T. H., Sharp, M. A., Heineman, T. C., Schleiss, M. R., & Dekker, C. L. (2006). Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults. VACCINE, 24(33-34), 5913-5918.

T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus
He, X. S., Draghi, M., Mahmood, K., Holmes, T. H., Kemble, G. W., & Greenberg, H. B. (2004). T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. JOURNAL OF CLINICAL INVESTIGATION, 114(12), 1812-1819.

Selective developmental defects of cord blood antigen-presenting cell subsets
Drohan, L., Harding, J. J., Holm, B., Cordoba-Tongson, E., Dekker, C. L., & Mellins, E. D. (2004). Selective developmental defects of cord blood antigen-presenting cell subsets. HUMAN IMMUNOLOGY, 65(11), 1356-1369.

Intestinal Imaging of children with acute rotavirus gastroenteritis
Bass, D., Cordoba, T., Dekker, T., Schuind, A., & Cassady, J. (2004). Intestinal Imaging of children with acute rotavirus gastroenteritis. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 39(3), 270-274.

Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood
Chen, S. F., Tu, W. W., Sharp, M. A., Tongson, E. C., He, X. S., & Arvin, A. M. (2004). Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood. JOURNAL OF INFECTIOUS DISEASES, 189(9), 1619-1627.

Persistent and selective deficiency of CD4(+) T cell immunity to cytomegalovirus in immunocompetent young children
Tu, W. W., Chen, S., Sharp, M., Dekker, C., Manganello, A. M., & Lewis, D. B. (2004). Persistent and selective deficiency of CD4(+) T cell immunity to cytomegalovirus in immunocompetent young children. JOURNAL OF IMMUNOLOGY, 172(5), 3260-3267.

Pediatric uses of valacyclovir, penciclovir and famciclovir
Dekker, C. L., & Prober, C. G. (2001). Pediatric uses of valacyclovir, penciclovir and famciclovir. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 20(11), 1079-1081.

Antiviral agents effective against herpesviruses.
Dekker, C. L., & Prober, C. G. (2001). Antiviral agents effective against herpesviruses. Current clinical topics in infectious diseases, 21, 271-301.

Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection - Two randomized controlled trials
Corey, L., Langenberg, A. Gm., Ashley, R., Sekulovich, R. E., Izu, A. E., & Straus, S. E. (1999). Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection - Two randomized controlled trials. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 282(4), 331-340.

Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: Results of a placebo-controlled vaccine trial
Straus, S. E., Wald, A., KOST, R. G., McKenzie, R., Langenberg, A. Gm., & Corey, L. (1997). Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: Results of a placebo-controlled vaccine trial. JOURNAL OF INFECTIOUS DISEASES, 176(5), 1129-1134.

Safety and immunogenicity of Chiron/Biocine(R) recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers
Black, S. B., Shinefield, H. R., Bergen, R., Hart, C., KREMERS, R., & Podda, A. (1997). Safety and immunogenicity of Chiron/Biocine(R) recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 16(1), 53-58.

Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59
Keefer, M. C., Graham, B. S., McElrath, M. J., Matthews, T. J., Stablein, D. M., & Dolin, R. (1996). Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. AIDS RESEARCH AND HUMAN RETROVIRUSES, 12(8), 683-693.

A RECOMBINANT GLYCOPROTEIN VACCINE FOR HERPES-SIMPLEX TYPE-2 - SAFETY AND EFFICACY
Langenberg, A. Gm., BURKE, R. L., ADAIR, S. F., SEKULOVICH, O., TIGGES, M., & Corey, L. (1995). A RECOMBINANT GLYCOPROTEIN VACCINE FOR HERPES-SIMPLEX TYPE-2 - SAFETY AND EFFICACY. ANNALS OF INTERNAL MEDICINE, 122(12), 889-898.

CLINICAL AND IMMUNOLOGICAL RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE 1(SF2) GP120 SUBUNIT VACCINE COMBINED WITH MF59 ADJUVANT WITH OR WITHOUT MURAMYL TRIPEPTIDE DIPALMITOYL PHOSPHATIDYLETHANOLAMINE IN NON-HIV-INFECTED HUMAN VOLUNTEERS
Kahn, J. O., Sinangil, F., Baenziger, J., Murcar, N., Wynne, D., & Chernoff, D. (1994). CLINICAL AND IMMUNOLOGICAL RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE 1(SF2) GP120 SUBUNIT VACCINE COMBINED WITH MF59 ADJUVANT WITH OR WITHOUT MURAMYL TRIPEPTIDE DIPALMITOYL PHOSPHATIDYLETHANOLAMINE IN NON-HIV-INFECTED HUMAN VOLUNTEERS. JOURNAL OF INFECTIOUS DISEASES, 170(5), 1288-1291.

PLACEBO-CONTROLLED TRIAL OF VACCINATION WITH RECOMBINANT GLYCOPROTEIN-D OF HERPES-SIMPLEX VIRUS TYPE-2 FOR IMMUNOTHERAPY OF GENITAL HERPES
Straus, S. E., Corey, L., BURKE, R. L., SAVARESE, B., Barnum, G., & Dekker, C. L. (1994). PLACEBO-CONTROLLED TRIAL OF VACCINATION WITH RECOMBINANT GLYCOPROTEIN-D OF HERPES-SIMPLEX VIRUS TYPE-2 FOR IMMUNOTHERAPY OF GENITAL HERPES. LANCET, 343(8911), 1460-1463.

PILOT EVALUATION OF INFLUENZA-VIRUS VACCINE (IVV) COMBINED WITH ADJUVANT
Keitel, W., Couch, R., Bond, N., Adair, S., Vannest, G., & Dekker, C. (1993). PILOT EVALUATION OF INFLUENZA-VIRUS VACCINE (IVV) COMBINED WITH ADJUVANT. VACCINE, 11(9), 909-913.

INDUCTION AND ENHANCEMENT OF IMMUNE-RESPONSES TO HERPES-SIMPLEX VIRUS TYPE-2 IN HUMANS BY USE OF A RECOMBINATN GLYCOPROTEIN-D VACCINE
Straus, S. E., SAVARESE, B., TIGGES, M., Freifeld, A. G., Krause, P. R., & BURKE, R. L. (1993). INDUCTION AND ENHANCEMENT OF IMMUNE-RESPONSES TO HERPES-SIMPLEX VIRUS TYPE-2 IN HUMANS BY USE OF A RECOMBINATN GLYCOPROTEIN-D VACCINE. JOURNAL OF INFECTIOUS DISEASES, 167(5), 1045-1052.

UNRECOGNIZED PERTUSSIS INFECTION IN ADOLESCENTS
Cromer, B. A., Goydos, J., Hackell, J., Mezzatesta, J., Dekker, C., & Mortimer, E. A. (1993). UNRECOGNIZED PERTUSSIS INFECTION IN ADOLESCENTS. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 147(5), 575-577.

COMPARISON OF ACELLULAR AND WHOLE-CELL PERTUSSIS-COMPONENT DIPHTHERIA-TETANUS-PERTUSSIS VACCINES IN INFANTS
Blumberg, D. A., Mink, C. M., Cherry, J. D., Johnson, C., Garber, R., & Christenson, P. D. (1991). COMPARISON OF ACELLULAR AND WHOLE-CELL PERTUSSIS-COMPONENT DIPHTHERIA-TETANUS-PERTUSSIS VACCINES IN INFANTS. JOURNAL OF PEDIATRICS, 119(2), 194-204.

PROTECTIVE EFFICACY OF THE TAKEDA ACELLULAR PERTUSSIS-VACCINE COMBINED WITH DIPHTHERIA AND TETANUS TOXOIDS FOLLOWING HOUSEHOLD EXPOSURE OF JAPANESE CHILDREN
Mortimer, E. A., Kimura, M., Cherry, J. D., KUNOSAKAI, H., Stout, M. G., & Yamaoka, H. (1990). PROTECTIVE EFFICACY OF THE TAKEDA ACELLULAR PERTUSSIS-VACCINE COMBINED WITH DIPHTHERIA AND TETANUS TOXOIDS FOLLOWING HOUSEHOLD EXPOSURE OF JAPANESE CHILDREN. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 144(8), 899-904.

COMPARISON OF AN ACELLULAR PERTUSSIS-COMPONENT DIPHTHERIA-TETANUS-PERTUSSIS (DTP) VACCINE WITH A WHOLE-CELL PERTUSSIS-COMPONENT DTP VACCINE IN 17-MONTH-OLD TO 24-MONTH-OLD CHILDREN, WITH MEASUREMENT OF 69-KILODALTON OUTER-MEMBRANE PROTEIN ANTIBODY
Blumberg, D. A., Mink, C. M., Cherry, J. D., Reisinger, K. S., Blatter, M. M., & Christenson, P. D. (1990). COMPARISON OF AN ACELLULAR PERTUSSIS-COMPONENT DIPHTHERIA-TETANUS-PERTUSSIS (DTP) VACCINE WITH A WHOLE-CELL PERTUSSIS-COMPONENT DTP VACCINE IN 17-MONTH-OLD TO 24-MONTH-OLD CHILDREN, WITH MEASUREMENT OF 69-KILODALTON OUTER-MEMBRANE PROTEIN ANTIBODY. JOURNAL OF PEDIATRICS, 117(1), 46-51.

COMPARISON OF ACELLULAR AND WHOLE-CELL PERTUSSIS-COMPONENT DTP VACCINES - A MULTICENTER DOUBLE-BLIND-STUDY IN 4-YEAR-OLD TO 6-YEAR-OLD CHILDREN
MORGAN, C. Am., Blumberg, D. A., Cherry, J. D., Reisinger, K. S., Blatter, M. M., & Christenson, P. D. (1990). COMPARISON OF ACELLULAR AND WHOLE-CELL PERTUSSIS-COMPONENT DTP VACCINES - A MULTICENTER DOUBLE-BLIND-STUDY IN 4-YEAR-OLD TO 6-YEAR-OLD CHILDREN. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 144(1), 41-45.

VIRUS-RESISTANCE IN CLINICAL-PRACTICE
Dekker, C., ELLIS, M. N., McLaren, C., Hunter, G., Rogers, J., & Barry, D. W. (1983). VIRUS-RESISTANCE IN CLINICAL-PRACTICE. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 12, 137-152.

INVITRO SENSITIVITY TO ACYCLOVIR IN GENITAL HERPES-SIMPLEX VIRUSES FROM ACYCLOVIR-TREATED PATIENTS
McLaren, C., Corey, L., DEKKET, C., & Barry, D. W. (1983). INVITRO SENSITIVITY TO ACYCLOVIR IN GENITAL HERPES-SIMPLEX VIRUSES FROM ACYCLOVIR-TREATED PATIENTS. JOURNAL OF INFECTIOUS DISEASES, 148(5), 868-875.

OCULAR LESIONS IN MICE FOLLOWING INTRACEREBRAL INJECTION OF HERPES-SIMPLEX VIRUS TYPE-1
Peiffer, R. L., DEKKER, C. D., & Siegel, F. L. (1983). OCULAR LESIONS IN MICE FOLLOWING INTRACEREBRAL INJECTION OF HERPES-SIMPLEX VIRUS TYPE-1. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 24(8), 1070-1078.